These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 853565

  • 41. Structure and biological function of La Crosse G1 glycoprotein.
    Kingsford L.
    Prog Clin Biol Res; 1983; 123():157-66. PubMed ID: 6191342
    [No Abstract] [Full Text] [Related]

  • 42. La Crosse virus infection and disease in western North Carolina.
    Kappus KD, Calisher CH, Baron RC, Davenport J, Francy DB, Williams RM.
    Am J Trop Med Hyg; 1982 May; 31(3 Pt 1):556-60. PubMed ID: 7081548
    [Abstract] [Full Text] [Related]

  • 43. The S RNA genomic sequences of Inkoo, San Angelo, Serra do Navio, South River and Tahyna bunyaviruses.
    Huang C, Shope RE, Spargo B, Campbell WP.
    J Gen Virol; 1996 Aug; 77 ( Pt 8)():1761-8. PubMed ID: 8760423
    [Abstract] [Full Text] [Related]

  • 44. Infection rates of Aedes triseriatus following ingestion of La Crosse virus by the larvae.
    Miller BR, DeFoliart GR, Hansen WR, Yuill TM.
    Am J Trop Med Hyg; 1978 May; 27(3):605-8. PubMed ID: 27990
    [Abstract] [Full Text] [Related]

  • 45. Unusual transcripts in La Crosse virus-infected cells and the site for nucleocapsid assembly.
    Raju R, Kolakofsky D.
    J Virol; 1987 Mar; 61(3):667-72. PubMed ID: 3806796
    [Abstract] [Full Text] [Related]

  • 46. An avirulent G1 glycoprotein variant of La Crosse bunyavirus with defective fusion function.
    Gonzalez-Scarano F, Janssen RS, Najjar JA, Pobjecky N, Nathanson N.
    J Virol; 1985 Jun; 54(3):757-63. PubMed ID: 3889368
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Translational requirement of La Crosse virus S-mRNA synthesis: in vivo studies.
    Raju R, Kolakofsky D.
    J Virol; 1987 Jan; 61(1):96-103. PubMed ID: 3783827
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Genome sequence analysis of La Crosse virus and in vitro and in vivo phenotypes.
    Bennett RS, Ton DR, Hanson CT, Murphy BR, Whitehead SS.
    Virol J; 2007 May 08; 4():41. PubMed ID: 17488515
    [Abstract] [Full Text] [Related]

  • 56. Isolates of California encephalitis (La Crosse) virus from field-collected eggs and larvae of Aedes triseriatus: identification of the overwintering site of California encephalitis.
    Balfour HH, Edelman CK, Cook FE, Barton WI, Buzicky AW, Siem RA, Bauer H.
    J Infect Dis; 1975 Jun 08; 131(6):712-6. PubMed ID: 805813
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Inhibitors of protein synthesis inhibit both La Crosse virus S-mRNA and S genome syntheses in vivo.
    Raju R, Kolakofsky D.
    Virus Res; 1986 Jul 08; 5(1):1-9. PubMed ID: 3751285
    [Abstract] [Full Text] [Related]

  • 60. La Crosse virus nucleocapsid protein controls its own synthesis in mosquito cells by encapsidating its mRNA.
    Hacker D, Raju R, Kolakofsky D.
    J Virol; 1989 Dec 08; 63(12):5166-74. PubMed ID: 2573738
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.